EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudieOpen Access

Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT

Eric Lim iD, Rosie A Harris iD, Holly E McKeon iD, Timothy Jp Batchelor iD, Joel Dunning iD, Michael Shackcloth iD, Vladimir Anikin iD, Babu Naidu iD, Elizabeth Belcher iD, Mahmoud Loubani iD, Vipin Zamvar iD, Lucy Dabner iD und 8 weitere

Health Technology Assessment · 2022-12 · 26 (48) · 1-162

DOI: 10.3310/thbq1793 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Health Technology Assessment, 2022-12. Verfasst von Eric Lim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Academic Division of Thoracic Surgery, The Royal Brompton and Harefield Hospitals, London, UK. Hauptthemen laut MEDLINE: Thoracic Surgery, Video-Assisted, Lung Neoplasms. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health, Medical Research Council, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer is the leading cause of cancer death. Surgery remains the main method of managing early-stage disease. Minimal-access video-assisted thoracoscopic surgery results in less tissue trauma than open surgery; however, it is not known if it improves patient outcomes.

Objective

To compare the clinical effectiveness and cost-effectiveness of video-assisted thoracoscopic surgery lobectomy with open surgery for the treatment of lung cancer. Design, setting and participants A multicentre, superiority, parallel-group, randomised controlled trial with blinding of participants (until hospital discharge) and outcome assessors conducted in nine NHS hospitals. Adults referred for lung resection for known or suspected lung cancer, with disease suitable for both surgeries, were eligible. Participants were followed up for 1 year.

Interventions

Participants were randomised 1 : 1 to video-assisted thoracoscopic surgery lobectomy or open surgery. Video-assisted thoracoscopic surgery used one to four keyhole incisions without rib spreading. Open surgery used a single incision with rib spreading, with or without rib resection. Main outcome measures The primary outcome was self-reported physical function (using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30) at 5 weeks. Secondary outcomes included upstaging to pathologic node stage 2 disease, time from surgery to hospital discharge, pain in the first 2 days, prolonged pain requiring analgesia at > 5 weeks, adverse health events, uptake of adjuvant treatment, overall and disease-free survival, quality of life (Quality of Life Questionnaire Core 30, Quality of Life Questionnaire Lung Cancer 13 and EQ-5D) at 2 and 5 weeks and 3, 6 and 12 months, and cost-effectiveness.

Results

A total of 503 patients were randomised between July 2015 and February 2019 (video-assisted thoracoscopic surgery, n = 247; open surgery, n = 256). One participant withdrew before surgery. The mean age of patients was 69 years; 249 (49.5%) patients were men and 242 (48.1%) did not have a confirmed diagnosis. Lobectomy was performed in 453 of 502 (90.2%) participants and complete resection was achieved in 429 of 439 (97.7%) participants. Quality of Life Questionnaire Core 30 physical function was better in the video-assisted thoracoscopic surgery group than in the open-surgery group at 5 weeks (video-assisted thoracoscopic surgery, n = 247; open surgery, n = 255; mean difference 4.65, 95% confidence interval 1.69 to 7.61; p = 0.0089). Upstaging from clinical node stage 0 to pathologic node stage 1 and from clinical node stage 0 or 1 to pathologic node stage 2 was similar ( p ≥ 0.50). Pain scores were similar on day 1, but lower in the video-assisted thoracoscopic surgery group on day 2 (mean difference –0.54, 95% confidence interval –0.99 to –0.09; p = 0.018). Analgesic consumption was 10% lower (95% CI –20% to 1%) and the median hospital stay was less (4 vs. 5 days, hazard ratio 1.34, 95% confidence interval 1.09, 1.65; p = 0.006) in the video-assisted thoracoscopic surgery group than in the open-surgery group. Prolonged pain was also less (relative risk 0.82, 95% confidence interval 0.72 to 0.94; p = 0.003). Time to uptake of adjuvant treatment, overall survival and progression-free survival were similar ( p ≥ 0.28). Fewer participants in the video-assisted thoracoscopic surgery group than in the open-surgery group experienced complications before and after discharge from hospital (relative risk 0.74, 95% confidence interval 0.66 to 0.84; p < 0.001 and relative risk 0.81, 95% confidence interval 0.66 to 1.00; p = 0.053, respectively). Quality of life to 1 year was better across several domains in the video-assisted thoracoscopic surgery group than in the open-surgery group. The probability that video-assisted thoracoscopic surgery is cost-effective at a willingness-to-pay threshold of £20,000 per quality-adjusted life-year is 1.

Limitations

Ethnic minorities were under-represented compared with the UK population (< 5%), but the cohort reflected the lung cancer population.

Conclusions

Video-assisted thoracoscopic surgery lobectomy was associated with less pain, fewer complications and better quality of life without any compromise to oncologic outcome. Use of video-assisted thoracoscopic surgery is highly likely to be cost-effective for the NHS. Future work Evaluation of the efficacy of video-assisted thoracoscopic surgery with robotic assistance, which is being offered in many hospitals.

Trial registration

This trial is registered as ISRCTN13472721. Funding This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 26, No. 48. See the NIHR Journals Library website for further project information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thoracic Surgery, Video-AssistedLung NeoplasmsAdultMaleHumansAgedFemaleSelf ReportQuality of LifeCost-Benefit AnalysisPain

Stichwörter der Autor:innen

ANALGESIABIOPSYCARDIOTHORACIC SURGERYCOST-BENEFIT ANALYSISDISEASE PROGRESSIONDISEASE-FREE SURVIVALFROZEN SECTIONSINFORMED CONSENTINTENTION TO TREAT ANALYSISLENGTH OF STAYLOBECTOMYLUNG CANCERMINIMALLY INVASIVEONCOLOGYOPEN SURGERY

Autor:innen und Institutionen

  • Academic Division of Thoracic Surgery, The Royal Brompton and Harefield Hospitals, London, UK.
  • Clinical Trials and Evaluation Unit, Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Thoracic Surgery, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Department of Cardiothoracic Surgery, The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
  • Department of Thoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Department of Thoracic Surgery, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

ORCID-Profile: Eric Lim, Rosie A Harris, Holly E McKeon, Timothy Jp Batchelor, Joel Dunning, Michael Shackcloth, Vladimir Anikin, Babu Naidu, Elizabeth Belcher, Mahmoud Loubani, Vipin Zamvar, Lucy Dabner, Timothy Brush, Elizabeth A Stokes, Sarah Wordsworth, Sangeetha Paramasivan, Alba Realpe, Daisy Elliott, Jane Blazeby, Chris A Rogers

Förderung

  • Department of Health
  • Medical Research Council
  • British Heart Foundation
  • Health Technology Assessment programme

Zitieren

APA

Lim, E., Harris, R. A., McKeon, H. E., Batchelor, T. J., Dunning, J., Shackcloth, M., Anikin, V., Naidu, B., Belcher, E., Loubani, M., Zamvar, V., Dabner, L., Brush, T., Stokes, E. A., Wordsworth, S., Paramasivan, S., Realpe, A., Elliott, D., Blazeby, J., & Rogers, C. A. (2022). Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT. Health Technology Assessment, 26(48), 1-162. https://doi.org/10.3310/thbq1793

Vancouver

Lim E, Harris RA, McKeon HE, Batchelor TJ, Dunning J, Shackcloth M, et al. Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT. Health Technology Assessment. 2022;26(48):1-162. doi:10.3310/thbq1793

BibTeX
@article{Lim2022,
  author = {Lim, Eric and Harris, Rosie A and McKeon, Holly E and Batchelor, Timothy Jp and Dunning, Joel and Shackcloth, Michael and Anikin, Vladimir and Naidu, Babu and Belcher, Elizabeth and Loubani, Mahmoud and Zamvar, Vipin and Dabner, Lucy and Brush, Timothy and Stokes, Elizabeth A and Wordsworth, Sarah and Paramasivan, Sangeetha and Realpe, Alba and Elliott, Daisy and Blazeby, Jane and Rogers, Chris A},
  title = {Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT},
  journal = {Health Technology Assessment},
  year = {2022},
  volume = {26},
  number = {48},
  pages = {1--162},
  doi = {10.3310/thbq1793}
}
Kostenlos starten →